clarithromycin

clarithromycin is a lipid of Polyketides (PK) class. Clarithromycin is associated with abnormalities such as Helicobacter Pylori Infection, Infection, Coinfection, Gastritis and Peptic Ulcer. The involved functions are known as Point Mutation, Increased Sensitivy, Bacterial resistance, urease activity and Mutation. Clarithromycin often locates in Blood, Gastric mucosa, Biopsy sample, Respiratory System and Entire gastrointestinal tract. The associated genes with clarithromycin are Genes, rRNA, rRNA Operon, Genome, HM13 gene and GDF15 gene. The related lipids are 9,11-linoleic acid, Steroids, Lysophosphatidylcholines, Lipopolysaccharides and 4-hydroxycholesterol. The related experimental models are Mouse Model, Knock-out and Experimental Pneumococcal Meningitis.

Cross Reference

Introduction

To understand associated biological information of clarithromycin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with clarithromycin?

clarithromycin is suspected in Infection, Helicobacter Pylori Infection, Pneumonia, Respiratory Tract Infections, PARKINSON DISEASE, LATE-ONSET, Community acquired pneumonia and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with clarithromycin

MeSH term MeSH ID Detail
Abnormalities, Drug-Induced D000014 10 associated lipids
Abortion, Spontaneous D000022 12 associated lipids
Abscess D000038 13 associated lipids
Achlorhydria D000126 1 associated lipids
Actinomycetales Infections D000193 4 associated lipids
Adenocarcinoma D000230 166 associated lipids
Angina Pectoris D000787 27 associated lipids
Arrhythmias, Cardiac D001145 42 associated lipids
Arteriosclerosis D001161 86 associated lipids
Arthritis D001168 41 associated lipids
Arthritis, Infectious D001170 8 associated lipids
Bacterial Infections D001424 21 associated lipids
Bacteriuria D001437 7 associated lipids
Barrett Esophagus D001471 3 associated lipids
Bartonella Infections D001474 3 associated lipids
Body Weight D001835 333 associated lipids
Boutonneuse Fever D001907 5 associated lipids
Bradycardia D001919 13 associated lipids
Bronchial Spasm D001986 18 associated lipids
Bronchiectasis D001987 7 associated lipids
Bronchiolitis D001988 6 associated lipids
Bronchiolitis Obliterans D001989 8 associated lipids
Bronchitis D001991 6 associated lipids
Carcinoma, Basal Cell D002280 6 associated lipids
Cardiovascular Diseases D002318 24 associated lipids
Cell Transformation, Neoplastic D002471 126 associated lipids
Chlamydia Infections D002690 7 associated lipids
Chromoblastomycosis D002862 2 associated lipids
Colitis D003092 69 associated lipids
Confusion D003221 4 associated lipids
Conjunctival Neoplasms D003230 3 associated lipids
Conjunctivitis, Bacterial D003234 3 associated lipids
Cross Infection D003428 9 associated lipids
Cystic Fibrosis D003550 65 associated lipids
Cysts D003560 4 associated lipids
Dermatitis, Exfoliative D003873 10 associated lipids
Drug Eruptions D003875 30 associated lipids
Dermatomycoses D003881 17 associated lipids
Diabetes Mellitus, Type 1 D003922 56 associated lipids
Diabetes Mellitus, Type 2 D003924 87 associated lipids
Diarrhea D003967 32 associated lipids
Diphtheria D004165 2 associated lipids
Drug Hypersensitivity D004342 20 associated lipids
Duodenitis D004382 4 associated lipids
Duodenogastric Reflux D004383 2 associated lipids
Dyspepsia D004415 5 associated lipids
Dyspnea D004417 10 associated lipids
Ecchymosis D004438 3 associated lipids
Empyema D004653 3 associated lipids
Empyema, Tuberculous D004654 1 associated lipids
Per page 10 20 50 100 | Total 242

PubChem Associated disorders and diseases

What pathways are associated with clarithromycin

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with clarithromycin?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with clarithromycin?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with clarithromycin?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with clarithromycin?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with clarithromycin?

Mouse Model

Mouse Model are used in the study 'Inflammation provoked by Mycoplasma pneumoniae extract: implications for combination treatment with clarithromycin and dexamethasone.' (Hirao S et al., 2011), Mouse Model are used in the study 'Tolerance and pharmacokinetic interactions of rifabutin and clarithromycin in human immunodeficiency virus-infected volunteers.' (Hafner R et al., 1998), Mouse Model are used in the study 'Clarithromycin attenuates mastectomy-induced acute inflammatory response.' (Chow LW et al., 2000) and Mouse Model are used in the study 'In vitro and in vivo influence of adjunct clarithromycin on the treatment of mucoid Pseudomonas aeruginosa.' (Bui KQ et al., 2000).

Knock-out

Knock-out are used in the study 'Intrinsic macrolide resistance in Mycobacterium smegmatis is conferred by a novel erm gene, erm(38).' (Nash KA, 2003).

Experimental Pneumococcal Meningitis

Experimental Pneumococcal Meningitis are used in the study 'Failure of treatment for chronic Mycobacterium abscessus meningitis despite adequate clarithromycin levels in cerebrospinal fluid.' (Maniu CV et al., 2001).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with clarithromycin

Download all related citations
Per page 10 20 50 100 | Total 7636
Authors Title Published Journal PubMed Link
Srivastava S et al. Therapeutic drug management: is it the future of multidrug-resistant tuberculosis treatment? 2013 Eur. Respir. J. pmid:24293417
[Clarithromycin therapy for patients with cystic fibrosis: a randomized controlled trial]. 2013 Jpn J Antibiot pmid:24930240
Sasaki H et al. Ten-year trend of the cumulative Helicobacter pylori eradication rate for the 'Japanese eradication strategy'. 2013 Digestion pmid:24356705
Yakoob J et al. Low rate of recurrence of Helicobacter pylori infection in spite of high clarithromycin resistance in Pakistan. 2013 BMC Gastroenterol pmid:23433429
Amin M et al. Anti-Helicobacter pylori and urease inhibition activities of some traditional medicinal plants. 2013 Molecules pmid:23434867
Kato H et al. Addition of clarithromycin to lenalidomide/low-dose dexamethasone was effective in a case of relapsed myeloma after long-term use of lenalidomide. 2013 Ann. Hematol. pmid:23625297
Bolhuis MS et al. Clinical validation of the analysis of linezolid and clarithromycin in oral fluid of patients with multidrug-resistant tuberculosis. 2013 Antimicrob. Agents Chemother. pmid:23689722
Togami K et al. Subcellular distribution of azithromycin and clarithromycin in rat alveolar macrophages (NR8383) in vitro. 2013 Biol. Pharm. Bull. pmid:23995662
Kim SG et al. Helicobacter pylori eradication on iatrogenic ulcer by endoscopic resection of gastric tumour: a prospective, randomized, placebo-controlled multi-centre trial. 2013 Dig Liver Dis pmid:23333104
Lim JH et al. Clinical outcomes of two-week sequential and concomitant therapies for Helicobacter pylori eradication: a randomized pilot study. 2013 Helicobacter pmid:23305083
Feng Z et al. Dissociative disorder induced by clarithromycin combined with rabeprazole in a patient with gastritis. 2013 J. Int. Med. Res. pmid:23569151
Gokmen T et al. Clarithromycin treatment in preterm infants: a pilot study for prevention of feeding intolerance. 2013 J. Matern. Fetal. Neonatal. Med. pmid:23570248
Faraji F et al. The effect of Helicobacter pylori eradication on migraine: a randomized, double blind, controlled trial. 2012 Nov-Dec Pain Physician pmid:23159967
Eremenko AA et al. [Effect of clarithromycin on the systemic inflammatory response syndrome severity in patients after myocardial revascularization surgery]. 2012 May-Jun Anesteziol Reanimatol pmid:22993930
Singh V et al. Vesicular palmoplantar pityriasis rosea. 2012 Mar-Apr Skinmed pmid:22545332
Gutiérrez-Castrellón P et al. Efficacy and safety of clarithromycin in pediatric patients with upper respiratory infections: a systematic review with meta-analysis. 2012 Mar-Apr Rev. Invest. Clin. pmid:22991774
Rajendiran S et al. Increased protein carbonylation and decreased antioxidant status in anemic H. pylori infected patients: effect of treatment. 2012 Jul-Aug Saudi J Gastroenterol pmid:22824768
De Sanctis V et al. Anti-Helicobacter pylori therapy in primary MALT lymphoma of rectum. 2012 Jul-Aug Tumori pmid:23052174
Figueroa M et al. [Antimicrobial susceptibility of Helicobacter pylori with chronic gastritis]. 2012 Jan-Mar Biomedica pmid:23235785
de Lalibera IB et al. Meningoencephalitis associated with Mycoplasma pneumoniae. 2012 Jan-Mar Einstein (Sao Paulo) pmid:23045836
Dhillon GS et al. Clarithromycin for prevention of bronchiolitis obliterans syndrome in lung allograft recipients. 2012 Jan-Feb Clin Transplant pmid:21352378
Onsun N et al. Impact of Helicobacter pylori infection on severity of psoriasis and response to treatment. 2012 Jan-Feb Eur J Dermatol pmid:22063790
Montero-Tinnirello J et al. [Pulmonary hemorrhage due to leptospirosis]. 2012 Jan-Feb Med Intensiva pmid:21592620
Dai WQ et al. The eradicating Helicobacter pylori infection in duodenal ulcer patients by three short-term triple therapies in China: a multicenter clinical comparative study. 2012 Jan-Feb Hepatogastroenterology pmid:22260837
Matsushima M and Takagi A "Is it effective?" to "How to use it?": the era has changed in probiotics and functional food products against Helicobacter pylori infection. 2012 J. Gastroenterol. Hepatol. pmid:22515805
Fujita Y et al. Pulmonary Actinomyces graevenitzii infection presenting as organizing pneumonia diagnosed by PCR analysis. 2012 J. Med. Microbiol. pmid:22516132
Albaugh DR et al. Time-dependent inhibition and estimation of CYP3A clinical pharmacokinetic drug-drug interactions using plated human cell systems. 2012 Drug Metab. Dispos. pmid:22490230
Malfertheiner P et al. Management of Helicobacter pylori infection--the Maastricht IV/ Florence Consensus Report. 2012 Gut pmid:22491499
Huang YK et al. Lansoprazole-based sequential and concomitant therapy for the first-line Helicobacter pylori eradication. 2012 J Dig Dis pmid:22435509
Padovan J et al. Investigating the barriers to bioavailability of macrolide antibiotics in the rat. 2012 Eur J Drug Metab Pharmacokinet pmid:22113743
Walkey AJ and Wiener RS Macrolide antibiotics and survival in patients with acute lung injury. 2012 Chest pmid:22116799
Reva I et al. Virulence genotypes and drug resistance of Helicobacter pylori from Vladivostok, Russia: another feature in the Far East. 2012 Microbiol. Immunol. pmid:22211953
Park SJ et al. Fulminant and Fatal Multiple Organ Failure in a 12-Year-Old Boy With Mycoplasma pneumoniae Infection. 2012 Allergy Asthma Immunol Res pmid:22211173
Falkinham JO et al. Antibacterial activities of dendritic amphiphiles against nontuberculous mycobacteria. 2012 Tuberculosis (Edinb) pmid:22209468
Hutson JR et al. Use of clarithromycin and adverse cardiovascular events among older patients receiving donepezil: a population-based, nested case-control study. 2012 Drugs Aging pmid:22372724
Hegazy SK et al. Effect of clarithromycin and fluconazole on the pharmacokinetics of montelukast in human volunteers. 2012 Eur. J. Clin. Pharmacol. pmid:22392555
Valizadeh H et al. Antibacterial activity of clarithromycin loaded PLGA nanoparticles. 2012 Pharmazie pmid:22393833
Togami K et al. Aerosol-based efficient delivery of clarithromycin, a macrolide antimicrobial agent, to lung epithelial lining fluid and alveolar macrophages for treatment of respiratory infections. 2012 J Aerosol Med Pulm Drug Deliv pmid:22360316
Gisbert JP and Calvet X Review article: rifabutin in the treatment of refractory Helicobacter pylori infection. 2012 Aliment. Pharmacol. Ther. pmid:22129228
Shiotani A et al. H. pylori eradication did not improve dysregulation of specific oncogenic miRNAs in intestinal metaplastic glands. 2012 J. Gastroenterol. pmid:22382634
Nujić K et al. Valosin containing protein (VCP) interacts with macrolide antibiotics without mediating their anti-inflammatory activities. 2012 Eur. J. Pharmacol. pmid:22209877
Hiramatsu M et al. Risk factors that affect the surgical outcome in the management of focal bronchiectasis in a developed country. 2012 Ann. Thorac. Surg. pmid:22119119
Kanazu T et al. Investigation of drug-drug interaction via mechanism-based inhibition of cytochrome P450 3A by macrolides in dexamethasone-treated female rats. 2012 Biopharm Drug Dispos pmid:22447511
Togami K et al. Transport characteristics of clarithromycin, azithromycin and telithromycin, antibiotics applied for treatment of respiratory infections, in Calu-3 cell monolayers as model lung epithelial cells. 2012 Pharmazie pmid:22764569
Konorev MR [Use of the immunopotentiator N-acetyl-glucosamine-N-acetylmuramyl dipeptide during triple anti-Helicobacter pylori therapy]. 2012 Ter. Arkh. pmid:23479993
Inamo Y et al. A 7-year-old girl with subcutaneous emphysema, pneumomediastinum, pneumothorax, and pneumoretroperitoneum caused by Mycoplasma pneumoniae pneumonia. 2012 J. Infect. Chemother. pmid:21901497
Sezikli M et al. Supplementing vitamins C and E to standard triple therapy for the eradication of Helicobacter pylori. 2012 J Clin Pharm Ther pmid:21740452
Liang J et al. Helicobacter pylori eradication with ecabet sodium, omeprazole, amoxicillin, and clarithromycin versus bismuth, omeprazole, amoxicillin, and clarithromycin quadruple therapy: a randomized, open-label, phase IV trial. 2012 Helicobacter pmid:23066868
Erol E et al. Antibiotic susceptibility patterns of Crossiella equi and Amycolatopsis species causing nocardioform placentitis in horses. 2012 J. Vet. Diagn. Invest. pmid:23051830
Dalkmann P et al. Accumulation of pharmaceuticals, Enterococcus, and resistance genes in soils irrigated with wastewater for zero to 100 years in central Mexico. 2012 PLoS ONE pmid:23049795
Kurugol Z et al. Severe Hemolytic Anemia Associated with Mild Pneumonia Caused by Mycoplasma pneumonia. 2012 Case Rep Med pmid:23049568
Deng ZH et al. Influence of Helicobacter pylori infection on ghrelin levels in children. 2012 World J. Gastroenterol. pmid:23049220
Malfertheiner P et al. Helicobacter pylori: clinical management. 2012 Curr. Opin. Gastroenterol. pmid:23010682
Rimbara E et al. Molecular epidemiologic analysis and antimicrobial resistance of Helicobacter cinaedi isolated from seven hospitals in Japan. 2012 J. Clin. Microbiol. pmid:22593597
Kant S et al. Extra-pulmonary primary multidrug-resistant tubercular lymphadenitis in an HIV negative patient. 2012 BMJ Case Rep pmid:22605844
Kotsaki A and Giamarellos-Bourboulis EJ Emerging drugs for the treatment of sepsis. 2012 Expert Opin Emerg Drugs pmid:22780561
Kurinčič M et al. Epigallocatechin gallate as a modulator of Campylobacter resistance to macrolide antibiotics. 2012 Int. J. Antimicrob. Agents pmid:22999765
Korkmaz S et al. Unusual manifestations of acute Q fever: autoimmune hemolytic anemia and tubulointerstitial nephritis. 2012 Ann. Clin. Microbiol. Antimicrob. pmid:22607576
Fiorini G et al. Newer agents for Helicobacter pylori eradication. 2012 Clin Exp Gastroenterol pmid:22767998
Whittemore KR and Cohen M Imaging and review of a large pre-auricular pilomatrixoma in a child. 2012 World J Radiol pmid:22761984
Oh HS et al. Ten-day sequential therapy is more effective than proton pump inhibitor-based therapy in Korea: a prospective, randomized study. 2012 J. Gastroenterol. Hepatol. pmid:21916989
Suzuki H et al. Molecular approaches and modern clinical strategies for the management of Helicobacter pylori infection in Japan. 2012 Keio J Med pmid:23324305
Kudo T et al. Comparison of lafutidine and rabeprazole in 7-day second-line amoxicillin- and metronidazole-containing triple therapy for Helicobacter pylori: a pilot study. 2012 Helicobacter pmid:22759327
Wong BC et al. Effects of selective COX-2 inhibitor and Helicobacter pylori eradication on precancerous gastric lesions. 2012 Gut pmid:21917649
Roccarina D et al. Different Antibiotic No Culture Eradicating (DANCE) strategy: an easy way to manage H. pylori eradication. 2012 Dig Liver Dis pmid:22743557
Tursi A et al. Efficacy and tolerability of a third-line, levofloxacin-based, 10-day sequential therapy in curing resistant Helicobacter pylori infection. 2012 J Gastrointestin Liver Dis pmid:22720300
O'Connor MB et al. Rituximab-induced pulmonary disease. 2012 Rheumatol. Int. pmid:21892654
Nakagawa T et al. [Multicenter study on clinical features and genetic characteristics of Mycobacterium avium strains from patients in Japan with lung disease caused by M. avium]. 2012 Kekkaku pmid:23367826
Birteksöz-Tan AS and Zeybek Z Postantibiotic effect of various antibiotics on Legionella pneumophila strains isolated from water systems. 2012 Folia Microbiol. (Praha) pmid:22627604
Burt HJ et al. Progress curve mechanistic modeling approach for assessing time-dependent inhibition of CYP3A4. 2012 Drug Metab. Dispos. pmid:22621802
Bermudez LE et al. Identification of (+)-erythro-mefloquine as an active enantiomer with greater efficacy than mefloquine against Mycobacterium avium infection in mice. 2012 Antimicrob. Agents Chemother. pmid:22615290
Khan A et al. Antibiotic resistance and cagA gene correlation: a looming crisis of Helicobacter pylori. 2012 World J. Gastroenterol. pmid:22611319
Kjoller E et al. Good interobserver agreement was attainable on outcome adjudication in patients with stable coronary heart disease. 2012 J Clin Epidemiol pmid:22257841
Suzuki T Meibomitis-related keratoconjunctivitis: implications and clinical significance of meibomian gland inflammation. 2012 Cornea pmid:23038034
Kamada T et al. [Case of acute pharyngitis caused by Corynebacterium ulcerans in Ibaraki Prefecture]. 2012 Nippon Jibiinkoka Gakkai Kaiho pmid:22991854
Ichiki H et al. [A study of adverse drug reactions in the treatment of pulmonary Mycobacterium avium complex disease]. 2012 Kekkaku pmid:22993889
Schluger NW Treatment of pulmonary Mycobacterium avium complex infections: do drug levels matter? 2012 Am. J. Respir. Crit. Care Med. pmid:23071188
Li K and Haber RM Stevens-Johnson syndrome without skin lesions (Fuchs syndrome): a literature review of adult cases with Mycoplasma cause. 2012 Arch Dermatol pmid:22911206
Alfakry H et al. The association of serum neutrophil markers and acute coronary syndrome. 2012 Scand. J. Immunol. pmid:22537345
Shaifali I et al. Antibiotic susceptibility patterns of urinary pathogens in female outpatients. 2012 N Am J Med Sci pmid:22536558
Gisbert JP Rescue Therapy for Helicobacter pylori Infection 2012. 2012 Gastroenterol Res Pract pmid:22536225
Lee RP et al. Mycobacterium chelonae infection after total knee arthroplasty: a case report. 2012 J Orthop Surg (Hong Kong) pmid:22535831
Senhorinho GN et al. Occurrence and antimicrobial susceptibility of Porphyromonas spp. and Fusobacterium spp. in dogs with and without periodontitis. 2012 Anaerobe pmid:22609780
Adrjanowicz K et al. Molecular dynamics in supercooled liquid and glassy states of antibiotics: azithromycin, clarithromycin and roxithromycin studied by dielectric spectroscopy. Advantages given by the amorphous state. 2012 Mol. Pharm. pmid:22540343
Lulitanond A et al. Prevalence of β-lactamase-negative ampicillin-resistant haemophilus influenzae isolated from patients of a teaching hospital in Thailand. 2012 Jpn. J. Infect. Dis. pmid:22446118
Liang Y et al. Epidemiological and molecular characteristics of clinical isolates of Streptococcus pyogenes collected between 2005 and 2008 from Chinese children. 2012 J. Med. Microbiol. pmid:22442290
Gomez-Abreo D et al. [Chronic necrotizing pulmonary aspergillosis following an infection by Mycobacterium malmoense]. 2012 Rev Mal Respir pmid:22440310
Aoyama N et al. Clarithromycin suppresses the periodontal bacteria-accelerated abdominal aortic aneurysms in mice. 2012 J. Periodont. Res. pmid:22181324
Slany M et al. Mycobacterium marinum infections in humans and tracing of its possible environmental sources. 2012 Can. J. Microbiol. pmid:22182182
Guillot S et al. Macrolide-resistant Bordetella pertussis infection in newborn girl, France. 2012 Emerging Infect. Dis. pmid:22608348
Carella AM et al. Clarithromycin potentiates tyrosine kinase inhibitor treatment in patients with resistant chronic myeloid leukemia. 2012 Leuk. Lymphoma pmid:22233113
Lee JH et al. A nanohybrid system for taste masking of sildenafil. 2012 Int J Nanomedicine pmid:22619517
van Ingen J et al. The pharmacokinetics and pharmacodynamics of pulmonary Mycobacterium avium complex disease treatment. 2012 Am. J. Respir. Crit. Care Med. pmid:22744719
Terada M et al. Antimicrobial efficacies of several antibiotics against uterine cervicitis caused by Mycoplasma genitalium. 2012 J. Infect. Chemother. pmid:22020630
Song JY et al. Case series of mycobacterium abscessus infections associated with a trigger point injection and epidural block at a rural clinic. 2012 Epidemiol Health pmid:22323979
Hirata Y et al. Sitafloxacin resistance in Helicobacter pylori isolates and sitafloxacin-based triple therapy as a third-line regimen in Japan. 2012 Int. J. Antimicrob. Agents pmid:22321702
Pereyre S et al. Clonal spread of Mycoplasma pneumoniae in primary school, Bordeaux, France. 2012 Emerging Infect. Dis. pmid:22305177
Butler CC et al. Effectiveness of multifaceted educational programme to reduce antibiotic dispensing in primary care: practice based randomised controlled trial. 2012 BMJ pmid:22302780
Anand TD et al. Superantigen profiles of emm and emm-like typeable and nontypeable pharyngeal streptococcal isolates of South India. 2012 Ann. Clin. Microbiol. Antimicrob. pmid:22296671
Correia M et al. Docosahexaenoic acid inhibits Helicobacter pylori growth in vitro and mice gastric mucosa colonization. 2012 PLoS ONE pmid:22529974